stonks4u
Log inSign up free
INBS logo

INBS Intelligent Bio Solutions Inc.

NASDAQ Capital Market · Medical - Diagnostics & Research · Healthcare

$3.37
+0.60 (+21.66%)

Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond…

Market Cap: $2.18Mibs.inc

Price

No data yet.

Signal Score (90d)

100
100
Aug 17Aug 17

Revenue

$1.06M-34.02%
$0.00$535.9K$1.07M$1.61M
Jun 2021Mar 2026

Quote

Day Range
$2.86 – $3.49
52-Week Range
$1.52 – $24.90
Volume
$238.2K
Market Cap
$2.18M
50-Day Avg
$2.15
200-Day Avg
$4.84
Prev Close
$2.77
Open
$2.86

Valuation & Ratios

P/E Ratio
-0.86
EPS
$-20.04
P/B Ratio
3.03
P/S Ratio
2.97
Debt/Equity
0.09
Current Ratio
0.77
Dividend Yield
+0.0%
Gross Margin
+40.8%

Returns & Efficiency

Return on Equity
-352.7%
Return on Assets
-128.1%
FCF Yield
-109.2%
EV/EBITDA
-0.88

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$3.05M$-10.57M$-20.00
2024$3.11M$-10.16M$-63.80
2023$1.26M$-10.63M$-105.80
2022$0.00$-8.31M$-113.30
2021$1.98M$-7.04M$-162.20

Social Signal Score

50
5d
51
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Earnings

Fri, Aug 21(in 3 days)

Consensus estimate $-1.58 per share

0of 6 quarters beat consensus

Typical surprise -166.7% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, May 12$-1.80 vs $1.40miss
  • Thu, Feb 12$-2.82 vs $0.40miss
  • Thu, Nov 13$-3.50 vs $-1.50miss
  • Fri, Aug 15$-3.60 vs $-1.20miss
  • Wed, May 14$-4.40 vs $-2.80miss
  • Fri, Feb 14$-5.00 vs $-3.20miss

Estimates and results for INBS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Insider trading

Open-market buys and sells by INBS officers and directors.

Bought
$67k

8 trades

Sold
—

0 trades

  • Towers Christopherbought
    director·9,090 @ $0.55·$5k·Oct 4, 2023·filing
  • Towers Christopherbought
    director·9,090 @ $0.00·Oct 4, 2023·filing
  • Towers Christopherbought
    director·9,090 @ $0.00·Oct 4, 2023·filing
  • Sakiris Spiro Kevinbought
    Chief Financial Officer·112,727 @ $0.55·$62k·Oct 4, 2023·filing
  • Sakiris Spiro Kevinbought
    Chief Financial Officer·112,727 @ $0.00·Oct 4, 2023·filing
  • Sakiris Spiro Kevinbought
    Chief Financial Officer·112,727 @ $0.00·Oct 4, 2023·filing
  • Simeonidis Harrybought
    CEO·50 @ $1.85·$93·Sep 1, 2023·filing
  • Simeonidis Harrybought
    CEO·100 @ $1.92·$192·Aug 31, 2023·filing

18 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.

Valuation

INBShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsbenzinga.com·5h ago·Neutral

    Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action? Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) are surging Monday afternoon after the medical technology company announced a significant regulatory milestone for its rapid testing unit.

    View source ↗